Use of Antimalarial Drugs in Covid-19
Received Date: Aug 06, 2019 / Accepted Date: Sep 01, 2020 / Published Date: Sep 08, 2020
Abstract
During the recent pandemic of SARS-Covid-2 has made the clinicians to use other drugs that are known to be effective for other medical conditions. Among these repurposed therapeutic agents are the antimalarial drug chloroquine and its analogue hydroxy chloroquine, which is used for the treatment of autoimmune diseases such as SLE (systemic lupus erythematosus) and rhumatoid arthritis. These drugs have been noted having some antiviral properties in laboratory conditions. So, long story short these drugs along with a macrolide (azithromycin) were used extensively in the symptomatic treatment regimn of covid-19.
But the results came out however are a reminder of the risks of deciding to use medicines without clear evidence of their benefits and risks.
Keywords: SARS-Covid-19; Antimalarial drugs; Hydroxy chloroquine
Citation: Khan S (2020) Use of Antimalarial Drugs in Covid-19. Clin Pharmacol Biopharm 9: 205 Doi: 10.4172/2167-065X.1000205
Copyright: © 2020 Khan S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 1371
- [From(publication date): 0-2020 - Jul 17, 2024]
- Breakdown by view type
- HTML page views: 817
- PDF downloads: 554
